Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 3, 2025
Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia
Read more at globenewswire.com
